These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9700988)

  • 1. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
    Rossoni G; De Gennaro Colonna V; Bernareggi M; Polvani GL; Müller EE; Berti F
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):260-5. PubMed ID: 9700988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Eur J Pharmacol; 1997 Sep; 334(2-3):201-7. PubMed ID: 9369349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
    De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
    J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Cardiologia; 1997 Nov; 42(11):1165-72. PubMed ID: 9534309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
    Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
    Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
    Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
    Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat.
    Rossoni G; Locatelli V; De Gennaro Colonna V; Torsello A; Schweiger F; Boghen M; Nilsson M; Bernareggi M; Müller EE; Berti F
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):454-60. PubMed ID: 10471007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats.
    Berti F; Müller E; De Gennaro Colonna V; Rossoni G
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():149-52. PubMed ID: 10990152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protectant activity of defibrotide in cardioplegia followed by ischemia/reperfusion injury in the isolated rat heart.
    Rossoni G; Pompilio G; Biglioli P; Alamanni F; Tartara P; Rona P; Porqueddu M; Berti F
    J Card Surg; 1999; 14(5):334-41. PubMed ID: 10875586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post-ischaemic damage in rats.
    Facino RM; Carini M; Aldini G; Berti F; Rossoni G; Bombardelli E; Morazzoni P
    Life Sci; 1999; 64(8):627-42. PubMed ID: 10069526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model.
    Weekers F; Van Herck E; Isgaard J; Van den Berghe G
    Endocrinology; 2000 Nov; 141(11):3993-9. PubMed ID: 11089529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment.
    Torsello A; Rossoni G; Locatelli V; De Gennaro Colonna V; Bernareggi M; Francolini M; Müller EE; Berti F
    Endocrine; 2001 Feb; 14(1):109-12. PubMed ID: 11322492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
    Chen H; Zhang YC; Li D; Phillips MI; Mehta P; Shi M; Mehta JL
    J Pharmacol Exp Ther; 2000 Aug; 294(2):722-7. PubMed ID: 10900253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.
    Khandoudi N; Percevault-Albadine J; Bril A
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):443-51. PubMed ID: 9733358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction.
    Nishida Y; Minatoguchi S; Arai M; Takemura G; Uno Y; Hashimoto K; Wang N; Chen XH; Fujiwara T; Fujiwara H
    Heart Vessels; 2000; 15(6):268-73. PubMed ID: 11766064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.
    Bodart V; Bouchard JF; McNicoll N; Escher E; Carrière P; Ghigo E; Sejlitz T; Sirois MG; Lamontagne D; Ong H
    Circ Res; 1999 Oct; 85(9):796-802. PubMed ID: 10532947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
    Torsello A; Luoni M; Grilli R; Guidi M; Wehrenberg WB; Deghenghi R; Müller EE; Locatelli V
    Neuroendocrinology; 1997 Feb; 65(2):91-7. PubMed ID: 9067986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
    Broglio F; Guarracino F; Benso A; Gottero C; Prodam F; Granata R; Avogadri E; Muccioli G; Deghenghi R; Ghigo E
    Eur J Pharmacol; 2002 Jul; 448(2-3):193-200. PubMed ID: 12144941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyrroline derivative of mexiletine offers marked protection against ischemia/reperfusion-induced myocardial contractile dysfunction.
    Li H; Xu KY; Zhou L; Kalai T; Zweier JL; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2000 Nov; 295(2):563-71. PubMed ID: 11046089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.